Mechanisms of human papillomavirus type 16 neutralization by L2 cross-neutralizing and L1 type-specific antibodies

Keyphrases

• Antigen-antibody Complex 33%
• Capsid 66%
• Cell Surface 33%
• Cell Surface Binding 66%
• Cell Surface Interaction 66%
• Cellular Proteases 33%
• Cervical Cancer 33%
• Conformation Change 33%
• Conserved Sites 33%
• Cross-neutralization 100%
• Dominant Classes 33%
• Dynamic Model 33%
• Epitope 66%
• Etiological Agents 33%
• Extracellular Matrix 33%
• Furin 33%
• High-risk Human Papillomavirus (HR-HPV) 33%
• HPV Vaccine 33%
• HPV16 100%
• Neutralizing Antibodies 33%
• Neutralizing Epitope 100%
• Preventing Infection 33%
• Pseudovirion 33%
• Specific Antibodies 100%
• Type-specific 100%
• Vaccination 33%
• Viral 33%
• Virion 33%
• Virus-like 33%

Immunology and Microbiology

• Capsid 40%
• Cell Surface 100%
• Conformation 40%
• Dynamics 20%
• Epitope 100%
• Extracellular Matrix 20%
• HPV Vaccine 20%
• Human Papillomavirus Type 16 100%
• Monospecific Antibody 100%
• Neutralization 100%
• Neutralizing Antibody 20%
• Papillomaviridae 20%
• Serotype 20%
• Vaccination Policy 20%
• Virion 20%
• Virus-Like Particle 20%